Sight Sciences
Reimagining eyecare with transformative technology and an interventional mindset
Reimagining eyecare with transformative technology and an interventional mindset
Sight Sciences is a healthcare startup that was founded in 2011 and is headquartered in the United States. The company is focused on reimagining eyecare by leveraging transformative technology and an interventional mindset. Their vision is to enable interventions to occur earlier in order to preserve, protect, or restore natural eye function. Sight Sciences is dedicated to equipping eyecare providers with intuitive, less invasive, and more intelligent clinically-proven therapies. The startup recently secured a significant $35.00M Post-IPO Debt investment on 23 January 2024, with the funding coming from Hercules Capital. This investment highlights the confidence that investors have in Sight Sciences' innovative approach to eyecare and their potential to make a meaningful impact in the industry. With this financing, Sight Sciences is well-positioned to further develop and commercialize their transformative technologies, ultimately reshaping the eyecare landscape.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | $35.00M | 1 |
|
23 Jan 2024 |
| Venture Round | $23.25M | - | 09 Dec 2020 | |
| Series E | $30.00M | 1 |
|
18 Mar 2020 |
| Series D | $31.00M | 2 |
|
04 Sep 2019 |
| Series C | $10.00M | 1 |
|
09 Oct 2017 |
No recent news or press coverage available for Sight Sciences.
We care about your data, and we'd love to use cookies make your experience better.
